Literature DB >> 864102

Variation in theophylline clearance rate with time in chronic childhood asthma.

P Leung, A Kalisker, T D Bell.   

Abstract

Wide theophylline clearance rate (TCR) range between different individuals has been reported, but little is known about its change with the passage of time. Optimal theophylline therapy for asthma aimed at plasma or serum levels of 10 to 20 microng/ml is now strongly recommended. Significant TCR variability with time might easily result in theophylline levels in the toxic or subtherapeutic ranges. Thirty severe asthmatics (mean age, 13 yr) received 24 hr constant intravenous infusion of 1 mg/kg/hr aminophylline USP. TCR was determined after a steady state was reached. Twelve of these patients with persisting poorly controlled asthma underwent repeat infusion for TCR determination at intervals of 1 to 8 mo (mean, 4.7 mo). When these results were compared to the initial individual TCR, the mean absolute change was 28 +/- 24% (mean +/-SD). Thus, this significant individual variation in TCR with the passage of time (p less than 0.01) requires periodic monitoring of plasma theophylline levels in severe asthma treated by optimized theophylline dosage.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 864102     DOI: 10.1016/0091-6749(77)90007-0

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  12 in total

1.  Evaluation of the utility of a proposed method for correcting for intrasubject variability in metabolic clearance in the bioavailability assessment of theophylline.

Authors:  Y Kasuya; T Furuta; H Shibasaki; H Shimota
Journal:  J Pharmacokinet Biopharm       Date:  1991-02

Review 2.  Clinical pharmacokinetics of theophylline.

Authors:  R I Ogilvie
Journal:  Clin Pharmacokinet       Date:  1978 Jul-Aug       Impact factor: 6.447

3.  The effect of assay methods on plasma levels and pharmacokinetics of theophylline: HPLC and EIA.

Authors:  T Ishizaki; M Watanabe; N Morishita
Journal:  Br J Clin Pharmacol       Date:  1979-04       Impact factor: 4.335

Review 4.  Theophylline.

Authors:  E F Ellis
Journal:  Clin Rev Allergy       Date:  1983-03

5.  New method for bioavailability assessment of slow-release preparations of theophylline.

Authors:  Y Kasuya; T Ohno; N Kubota; H Takahashi; H Hirayama
Journal:  J Pharmacokinet Biopharm       Date:  1985-12

6.  Once a day theophylline; serum concentrations.

Authors:  V Nerminathan; S A McKenzie
Journal:  Arch Dis Child       Date:  1984-08       Impact factor: 3.791

7.  Intraindividual variability in theophylline pharmacokinetics: statistical verification in 39 of 60 healthy young adults.

Authors:  R A Upton; J F Thiercelin; T W Guentert; S M Wallace; J R Powell; L Sansom; S Riegelman
Journal:  J Pharmacokinet Biopharm       Date:  1982-04

8.  Lack of influence of an intensive antacid regimen on theophylline bioavailability.

Authors:  R C Reed; H J Schwartz
Journal:  J Pharmacokinet Biopharm       Date:  1984-06

9.  Altered theophylline pharmacokinetics during acute respiratory viral illness.

Authors:  K C Chang; T D Bell; B A Lauer; H Chai
Journal:  Lancet       Date:  1978-05-27       Impact factor: 79.321

10.  Determination of theophylline clearance in South African children.

Authors:  J H Botha; I Tyrannes; R Miller; A Wesley
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.